131 related articles for article (PubMed ID: 36706586)
1. The case of T-ALL presenting with NK phenotype after COVID-19 vaccination.
Yanagida E; Kubota A; Miyoshi H; Ohshima K; Kawakita T; Murayama T
Pathol Res Pract; 2023 Feb; 242():154310. PubMed ID: 36706586
[TBL] [Abstract][Full Text] [Related]
2. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
3. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient.
Kawano S; Tatsumi E; Yoneda N; Yamaguchi N; Goji J; Ito H; Nagai T; Nishikori M; Okamura A; Koiwai O
Hematol Oncol; 1995; 13(1):1-11. PubMed ID: 7538482
[TBL] [Abstract][Full Text] [Related]
4. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
5. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.
Ko YH; Ree HJ; Kim WS; Choi WH; Moon WS; Kim SW
Cancer; 2000 Nov; 89(10):2106-16. PubMed ID: 11066052
[TBL] [Abstract][Full Text] [Related]
7. T-lymphoblastic lymphoma/leukemia without clonal
Wang J; Jiang S; Zhao Q; Wei X; Li W
Transl Cancer Res; 2021 Mar; 10(3):1603-1608. PubMed ID: 35116486
[TBL] [Abstract][Full Text] [Related]
8. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
9. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
10. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group.
Weinberg OK; Chisholm KM; Ok CY; Fedoriw Y; Grzywacz B; Kurzer JH; Mason EF; Moser KA; Bhattacharya S; Xu M; Babu D; Foucar K; Tam W; Bagg A; Orazi A; George TI; Wang W; Wang SA; Arber DA; Hasserjian RP
Mod Pathol; 2021 Jul; 34(7):1358-1366. PubMed ID: 33526873
[TBL] [Abstract][Full Text] [Related]
11. CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features.
Lin CW; Liu TY; Chen SU; Wang KT; Medeiros LJ; Hsu SM
Blood; 2005 Nov; 106(10):3567-74. PubMed ID: 16046525
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic features and prognosis of T lymphoblastic lymphoma associated with Langerhans cell histiocytosis].
Li X; Wang Y; Chen R; Abulaiti D; Ma Z; Miao N; Abulajiang G; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):522-7. PubMed ID: 25346121
[TBL] [Abstract][Full Text] [Related]
13. Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report.
Ichinohasama R; Endoh K; Ishizawa K; Okuda M; Kameoka J; Meguro K; Myers J; Kadin ME; Mori S; Sawai T
Cancer; 1996 Jun; 77(12):2592-603. PubMed ID: 8640711
[TBL] [Abstract][Full Text] [Related]
14. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity.
Koita H; Suzumiya J; Ohshima K; Takeshita M; Kimura N; Kikuchi M; Koono M
Am J Surg Pathol; 1997 Feb; 21(2):242-8. PubMed ID: 9042293
[TBL] [Abstract][Full Text] [Related]
15. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic challenges in T-lymphoblastic lymphoma, early T-cell precursor acute lymphoblastic leukemia or mixed phenotype acute leukemia: A case report.
Wang P; Peng X; Deng X; Gao L; Zhang X; Feng Y
Medicine (Baltimore); 2018 Oct; 97(41):e12743. PubMed ID: 30313079
[TBL] [Abstract][Full Text] [Related]
17. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
18. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
Suzuki R; Nakamura S
Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
[TBL] [Abstract][Full Text] [Related]
19. CD56-positive acute lymphoblastic leukemia.
Matano S; Terahata S; Nakamura S; Kobayashi K; Sugimoto T
Acta Haematol; 2005; 114(3):160-3. PubMed ID: 16227680
[TBL] [Abstract][Full Text] [Related]
20. Blastic NK-cell lymphoma expressing terminal deoxynucleotidyl transferase with Homer-Wright type pseudorosettes formation.
Ko YH; Kim SH; Ree HJ
Histopathology; 1998 Dec; 33(6):547-53. PubMed ID: 9870150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
